Avellino Labs

Avellino Labs Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 40
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Avellino Labs General Information


Operator of a genetic testing laboratory intended to provide genetic testing and diagnostic services. The company's universal Test detects the TGFBI mutations that are responsible for Granular Corneal Dystrophy type 1 (GCD1), Granular Corneal Dystrophy type 2 (GCD2), Lattice Corneal Dystrophy type 1 (LCD1), Reis-Bucklers Corneal Dystrophy (RBCD), and Thiel Behnke Corneal Dystrophy (TBCD).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Primary Office
  • 1505 Adams Drive
  • Suite B2
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avellino Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue

Avellino Labs Executive Team (5)

Name Title Board Seat Contact Info
Chris Lehman Chief Financial Officer
Scott Korney Chief Operating Officer
Connie Chao-Shern Chief Laboratory Officer
Gene Lee Founder & Chairman

1 Former Executive

Avellino Labs Board Members (1)

Name Representing Role Since
Gene Lee Avellino Labs Founder & Chairman 000 0000

Avellino Labs Investors (1)

To view Avellino Labs‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
KIC Europe Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial